LABEL Opioids Act

Fact Sheet API

Bill Number

HR 1026

Introduced

Feb 11, 2021

Latest Action

Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.

Sponsor

Cosponsors

Topics

Administrative law and regulatory procedures Consumer affairs Crime and Law Enforcement Criminal justice information and records Department of Health and Human Services Drug safety, medical device, and laboratory regulation Drug trafficking and controlled substances Drug, alcohol, tobacco use Health information and medical records Prescription drugs

Full Text

View Full Bill Text

Votes

Summary

Lessening Addiction By Enhancing Labeling Opioids Act of 2021 or the LABEL Opioids Act

This bill requires prescription opioids to contain a warning label specifying that the opioids may cause dependence, addiction, and overdose. A registrant (e.g., a pharmacist) who dispenses an opioid in violation of the labeling requirement is subject to penalties.

Actions

Apr 28, 2021

Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Feb 12, 2021

Referred to the Subcommittee on Health.
Feb 11, 2021

Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Feb 11, 2021

Introduced in House

Amendments

Related Bills